{"product_id":"abcam-ab257548","title":"Abcam, ab257548, Human MYSM1 knockout HEK-293T cell lysate","description":"\u003cp\u003eSize: 1Kit\u003cbr\u003e\nMYSM1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR\/Cas9, 1 bp insertion in exon8 and 2 bp insertion in exon8.\u003cbr\u003e\nKey facts\u003cbr\u003e\nCell type:HEK-293T,\u003cbr\u003e\nSpecies or organism:Human,\u003cbr\u003e\nTissue:Kidney,\u003cbr\u003e\nKnockout validation:Sanger Sequencing,\u003cbr\u003e\nMutation description:Knockout achieved by using CRISPR\/Cas9, 1 bp insertion in exon8 and 2 bp insertion in exon8.\u003c\/p\u003e\n\n\u003cp\u003eProduct details:\u003cbr\u003e\nKnockout cell lysate achieved by CRISPR\/Cas9.\u003cbr\u003e\nREACH authorisation\u003cbr\u003e\nAbcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.\u003cbr\u003e\nIt is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.\u003cbr\u003e\nLysate preparation:\u003cbr\u003e\nOur lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10).\u003cbr\u003e\nThis means that the protein of interest is denatured.\u003cbr\u003e\nIf you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.\u003cbr\u003e\nUser storage instructions:\u003cbr\u003e\nLyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.\u003cbr\u003e\nThis product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our\u003cbr\u003e\nlimited use license\u003cbr\u003e\npatent pages\u003c\/p\u003e\n\n\u003cp\u003eProperties and Storage Information:\u003cbr\u003e\nGene name-MYSM1, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions--20°C, Appropriate long-term storage conditions--20°C\u003c\/p\u003e\n\n\u003cp\u003eSupplementary Information:\u003cbr\u003e\nThis supplementary information is collated from multiple sources and compiled automatically.\u003cbr\u003e\nMYSM1 also known as Myb-like SWIRM and MPN domains 1 functions as a histone H2A deubiquitinase. This protein weighs approximately 83 kDa. MYSM1 is found in the nucleus and shows expression in various tissues including hematopoietic cells such as T cells and bone marrow. By removing ubiquitin from histone H2A MYSM1 influences chromatin structure and gene transcription.\u003cbr\u003e\nBiological function summary\u003cbr\u003e\nMYSM1 plays an important role in regulating gene expression during processes like hematopoiesis and immune development. It forms part of a chromatin remodeling complex that modulates transcriptional activity by altering nucleosome configuration. This function is essential for proper stem cell maintenance and differentiation by ensuring that transcriptionally active and inactive regions are appropriately maintained and accessed.\u003cbr\u003e\nPathways\u003cbr\u003e\nMYSM1 participates in the ubiquitin-proteasome pathway and is involved in DNA damage response. It associates closely with proteins like TP53 where it aids in governing cell cycle progression and apoptosis. MYSM1 also interacts with histone modification machinery exerting effects on transcriptional silencing and activation particularly influencing genes associated with immune cell lineage commitment.\u003cbr\u003e\nMYSM1 impacts conditions such as bone marrow failure and immunodeficiency. It connects with the TP53 protein where mutations or dysregulation in this pathway can lead to hematological abnormalities and impaired immune function. MYSM1 deficiency has been implicated in defective T cell maturation and aberrant myeloid lineage decisions contributing to these disorders.\u003c\/p\u003e","brand":"Abcam","offers":[{"title":"Default Title","offer_id":46845126213801,"sku":"ab257548","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/ar\/products\/abcam-ab257548","provider":"Iright","version":"1.0","type":"link"}